Northern Trust Corp Longeveron Inc. Transaction History

Northern Trust Corp

  • $600 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024
BUY
$1.25 - $2.51 $48,912 - $98,216
39,130 Added 368.35%
49,753 $67,000
Q2 2022

Aug 12, 2022
BUY
$5.93 - $15.61 $62,994 - $165,825
10,623 New
10,623 $63,000

Others Institutions Holding LGVN

# of Institutions
2
Shares Held
1.18K
Call Options Held
0
Put Options Held
0
View Full List

About Longeveron Inc.

LGVN Quotes by TradingView
  • Ticker LGVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 5,925,940
  • Market Cap $9.78M
  • Description
  • Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions. The company's lead investigational product is the LOMECEL-B, a cell-based therapy product that is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young healthy adult ...
More about LGVN
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email